Factors associated with increased inpatient charges following aneurysmal subarachnoid hemorrhage with vasospasm: A nationwide analysis

Mualem, William; Durrani, Sulaman; Ghaith, Abdul Karim; Bhandarkar, Archis R.; Wahood, Waseem; Tjoumakaris, Stavropoula; Jabbour, Pascal; Bydon, Mohamad

doi:10.1016/j.clineuro.2022.107259

Cited by 6 publications

(4 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Inpatient hospital charges in the United States for patients with aSAH have been reported to be $373 353.94 and as much as $530 544.77 in those patients with aSAH who develop delayed cerebral ischemia (DCI). 21 These costs do not include posthospitalization costs associated with long-term care and rehabilitation or the societal cost of loss of work and productivity of patients with aSAH.…”

Section: General Conceptsmentioning

confidence: 99%

2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

Hoh¹,

Ko²,

Amin‐Hanjani³

et al. 2023

Stroke

265

145

View full text Add to dashboard Cite

AIM: The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage.” The 2023 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with aneurysmal subarachnoid hemorrhage. METHODS: A comprehensive search for literature published since the 2012 guideline, derived from research principally involving human subjects, published in English, and indexed in MEDLINE, PubMed, Cochrane Library, and other selected databases relevant to this guideline, was conducted between March 2022 and June 2022. In addition, the guideline writing group reviewed documents on related subject matter previously published by the American Heart Association. Newer studies published between July 2022 and November 2022 that affected recommendation content, Class of Recommendation, or Level of Evidence were included if appropriate. STRUCTURE: Aneurysmal subarachnoid hemorrhage is a significant global public health threat and a severely morbid and often deadly condition. The 2023 aneurysmal subarachnoid hemorrhage guideline provides recommendations based on current evidence for the treatment of these patients. The recommendations present an evidence-based approach to preventing, diagnosing, and managing patients with aneurysmal subarachnoid hemorrhage, with the intent to improve quality of care and align with patients’ and their families’ and caregivers’ interests. Many recommendations from the previous aneurysmal subarachnoid hemorrhage guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.

show abstract

Section: General Conceptsmentioning

confidence: 99%

2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

Hoh¹,

Ko²,

Amin‐Hanjani³

et al. 2023

Stroke

265

145

View full text Add to dashboard Cite

show abstract

“…There fore, the di ag no sis should be con firmed angiographically, for which some use TCD as a first-line di ag nos tic tool [8]. In other stud ies, CVS was con firmed in 30-75% of pa tients with SAH [12,15,21], but only in 7% of pa tients in this study.…”

Section: Discussionmentioning

confidence: 59%

“…[3,10,11]. CVS is linked to a high rate of mor bid ity and mor tal ity and may re quire mul ti ple treatments when re frac tory, which leads to higher treat ment costs and lon ger hos pi tal stays [12]. Thus, early de tec tion of CVS and other afore men tioned com pli ca tions is cru cial for im prov ing pa tient out comes.…”

mentioning

confidence: 99%

Retrospective study of spontaneous subarachnoid haemorrhage: vasospasm and other complications (Part III)

Bakanauskaitė,

Grigaitė,

Danilevičienė

et al. 2023

View full text Add to dashboard Cite

Background. Acute subarachnoid haemorrhage (SAH) is a dangerous condition: roughly 50% of patients die within 30 days, nearly 25% develop significant neuropsychological and cognitive deficits, about 10% suffer from other complications, and only around 15% recover fully. One of the main causes of mortality is cerebral vasospasm (CVS), a cause of delayed cerebral ischaemia (DCI), which can lead to secondary cerebral infarction. Thus, early detection of CVS is crucial for improving patient outcomes.The aim of this study was to analyse the demographic and clinical (including complications) data of patients diagnosed with SAH, to evaluate the diagnostic methods, and to investigate the prevalence and treatment of complications.Materials and methods. This retrospective study included 102 patients diagnosed with spontaneous SAH, aged at least 18 years, who were treated in the Vilnius University Hospital Santaros Klinikos (VUL SK) in 2014-2017. The obtained VUL SK data were selected by the I60 ICD-10-CM code and depersonalized. Head computerized tomography (CT), CT angiography (CTA), digital subtraction angiography (DSA), transcranial color-coded duplex sonography (TCCS), and magnetic resonance angiography (MRA) were used to evaluate the cerebral arteries.Results. In 102 patients (mean age 58±16 years; 55% female), the most common cause of spontaneous SAH was ruptured aneurysm, the most common arterial sites were the middle cerebral artery (36%), anterior cerebral artery and/or communicating artery (together 33%), and internal carotid artery (20%). In-hospital mortality was as high as 21%. All patients underwent head CT, 78% CTA, 33% DSA, 8% TCCS, and 1% MRA. 71% patients experienced SAH complications: 66% acute, 27% chronic. The most common acute complications were cerebral oedema (34%), rebleeding (29%), and acute ischaemia (23%), the most common chronic complications hydrocephalus (11%), DCI (9%), and CVS (8%).Conclusions. CVS was diagnosed considerably less frequently in this study compared to other studies. While the diagnosis rates of ischaemia and hyponatremia were likewise significantly lower in this study compared to those in others, they are in line with the CVS diagnosis rate. Aside from the CVS and CVS-related complications, all the other SAH complications were roughly within the range of the other studies.

show abstract

“…This burden is particularly high because, unlike other types of stroke, aSAH affects patients in their working years, with a mean age of 55 years ( 1 ). Moreover, aSAH imposes significant economic costs, with estimated inpatient hospital charges ranging from $373 353.94 to $530 544.77 [for those individuals with aSAH who develop delayed cerebral ischemia (DCI)] in the United States ( 5 ).…”

mentioning

confidence: 99%

Editorial: Improving aneurysmal Subarachnoid hemorrhage management, what's new?

Tardivo,

Crobeddu,

Del Sette

et al. 2024

Front. Neurol.

View full text Add to dashboard Cite

Factors associated with increased inpatient charges following aneurysmal subarachnoid hemorrhage with vasospasm: A nationwide analysis

Cited by 6 publications

References 28 publications

2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

Retrospective study of spontaneous subarachnoid haemorrhage: vasospasm and other complications (Part III)

Editorial: Improving aneurysmal Subarachnoid hemorrhage management, what's new?

Contact Info

Product

Resources

About